Dr Daniel Krell, Consultant Oncologist
Dr Daniel Krell
Consultant Oncologist
Dr Daniel Krell
Consultant Oncologist MBChB BSc MRCP Dphil
Dr Krell is a recommended Consultant Oncologist
Areas of expertise
- Chemotherapy
- Genetic testing
- Biological therapy
- Clinical trials
- Immunotherapy
Recommendations for Dr Krell
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
byDr Amit Majevadia, GP
❝Very approachable, great communication and would highly recommend Dr Krell for oncological care.❞
byProf. Giuseppe Kito Fusai, Consultant Hepato-Pancreato-Biliary Surgeon
❝I have the pleasure to recommend Dr Dan Krell, one of our best oncologists in the HPB Unit at the Royal Free Hospital. Dan is an excellent clinician with a specialist interest in Liver and Pancreato-Biliary cancer and he is involved in the various steps of the management of these patients, including pre and postoperative oncological treatments as well as palliative chemotherapy. His manners are exceptionally good which compliment a high level of proficiency.❞
byDr Steven Mann, Consultant Physician & Gastroenterologist
❝Dr Dan Krell is an experienced oncologist with excellent bedside manner and communication skills which parallels his knowledge and judgement. I respect his opinion and am grateful for his input into the care of our patients.❞
byMr Charles Imber, Consultant Hepatobiliary Pancreatic Surgeon
❝Highly recommend, thoroughly professional expert in his field.❞
by Dr Kalpesh Besherdas, Gastroenterologist
❝Dr Daniel Krell is an excellent communicator. He’s up-to-date in oncological treatment. He leads the upper GI cancer within our trust. I would recommend patients to him for upper gastrointestinal cancer treatment.❞
❝Very approachable, great communication and would highly recommend Dr Krell for oncological care.❞
byProf. Giuseppe Kito Fusai, Consultant Hepato-Pancreato-Biliary Surgeon
❝I have the pleasure to recommend Dr Dan Krell, one of our best oncologists in the HPB Unit at the Royal Free Hospital. Dan is an excellent clinician with a specialist interest in Liver and Pancreato-Biliary cancer and he is involved in the various steps of the management of these patients, including pre and postoperative oncological treatments as well as palliative chemotherapy. His manners are exceptionally good which compliment a high level of proficiency.❞
byDr Steven Mann, Consultant Physician & Gastroenterologist
❝Dr Dan Krell is an experienced oncologist with excellent bedside manner and communication skills which parallels his knowledge and judgement. I respect his opinion and am grateful for his input into the care of our patients.❞
byMr Charles Imber, Consultant Hepatobiliary Pancreatic Surgeon
❝Highly recommend, thoroughly professional expert in his field.❞
by Dr Kalpesh Besherdas, Gastroenterologist
❝Dr Daniel Krell is an excellent communicator. He’s up-to-date in oncological treatment. He leads the upper GI cancer within our trust. I would recommend patients to him for upper gastrointestinal cancer treatment.❞
Make an appointment
Address
-
The Harley Street Clinic
35 Weymouth St, London, W1G 8BJ
-
LOC at Chelsea
102 Sydney Street, Chelsea
-
Platinum Medical Centre
15-17, Lodge Road, London, NW8 7JA
-
The Wellington Hospital
St Johns Wood, London, NW8 7JA
-
Video consultation
Online, Video Consultation, W1
-
LOC - Leaders in Oncology Care
95 Harley Street, London, W1G 6AF
About Dr Daniel Krell
GMC number: 6075167
Year qualified: 2003
Place of primary qualification: University of Leeds
Dr Daniel Krell is a consultant oncologist at the Royal Free Trust, specialising in gastro-oesophageal, colorectal, pancreatic, liver, and bile duct cancers, as well as neuroendocrine tumours. He is highly experienced in administering chemotherapy, targeted therapy, and immunotherapy. Dr Krell also manages patients with cancer of unknown primary and serves as the clinical lead for this area.
Dr Krell is an integral member of the multidisciplinary team for gastro-oesophageal and hepatobiliary cancer at the Royal Free Trust. Additionally, he holds the position of clinical lead for neuroendocrine tumour oncology at The Royal Free Hospital.
Dr Krell completed his oncology training at University College and the Royal Free Hospitals in London. He holds a primary medical degree, a Bachelor’s degree in immunology and microbiology, and a DPhil in Clinical Medicine from the University of Oxford’s Wellcome Trust Centre for Human Genetics. His research, funded by Cancer Research UK and HCA, focused on the role of genetic mutations in genes controlling cellular metabolism in cancer development, potentially identifying new therapeutic targets.
Dr Krell remains actively involved in clinical research and trials aimed at discovering new cancer therapies, particularly for gastrointestinal, hepatobiliary, and neuroendocrine tumours. He has published numerous peer-reviewed papers and has presented his findings at both national and international conferences.
He treats a variety of conditions, including:
- Liver cancer
- Biliary cancer
- Bowel cancer
- Colorectal cancer
- Oesophageal cancer
- Pancreatic cancer
Dr Krell has been serving in his current roles since his appointment, bringing a wealth of knowledge and dedication to his patients and the medical community.
Areas of expertise
- Acute oncology
- Adenocarcinoma
- Bilary cancer
- Bile duct cancer (cholangiocarcinoma)
- Biological therapy
- Bowel cancer
- Cancer of unknown primary
- Chemotherapy
- Cholangiocarcinoma
- Clinical trials
- Colon cancer
- Colorectal cancer
- Gallbladder cancer
- Gastric cancer
- Gastrointestinal cancers
- Gastrointestinal stromal tumour (GIST)
- Gastro-oesophageal cancer
- Genetic testing
- Hepatocellular carcinoma
- Immunotherapy
- Liver cancer
- Molecular genetic profiling
- Neoadjuvant
- Neuroendocrine cancer
- Neuroendocrine tumours (NETS)
- Oesophageal cancer
- Pancreatic and biliary tract cancer
- Rectal cancer
- Small bowel cancer
- Targeted therapy
Professional memberships
Articles by Dr Daniel Krell
Idh mutations in tumorigenesis and their potential role as novel therapeutic targets
Ongoing adjuvant/neoadjuvant trials in resectable metastatic colorectal cancer
Screen for idh1, idh2, idh3, d2hgdh and l2hgdh mutations in glioblastoma
Audit of ca125 follow-up after first-line therapy for ovarian cancer
Impact of effective prevention and management of febrile neutropenia
Hot mutation screening in human glioblastomas
Other specialists recommended by Dr Krell
Dr David Feuer, Consultant in Palliative Medicine
❝Recommended palliative care specialist❞
Mr Charles Imber, Consultant Hepatobiliary Pancreatic Surgeon
❝Recommended hepato-biliary surgeon❞
Mr Matthew Welck, Consultant Orthopaedic Foot and Ankle Surgeon
❝Recommended orthopaedic surgeon❞
Dr Steven Mann, Consultant Physician & Gastroenterologist
❝Recommended Gastroenterologist❞
Dr Kwok Tang, Consultant Gastroenterologist and Hepatologist
❝Recommended Gastroenterologist❞
Mr Daren Francis, Consultant Colorectal & General Surgeon
❝Recommended general surgeon❞
Mr Colin Elton, Consultant General & Colorectal Surgeon
❝Recommended general surgeon❞
Prof. Giuseppe Kito Fusai, Consultant Hepato-Pancreato-Biliary Surgeon
❝Recommended general surgeon❞
Prof. Brian Davidson, Consultant in HPB & Liver Transplant Surgery
❝Recommended general surgeon❞
Prof. Bijendra Patel, Consultant Laparoscopic and General Surgeon
❝Recommended general surgeon❞
Dr Andres Virchis, Consultant Haemato-Oncologist
❝Recommended haematologist❞
Charity Gentry,
❝Recommended obstetrician & gynaecologist❞
Dr Rowan Hearn, Palliative Care Specialist
❝Recommended palliative care specialist❞
Dr Kalpesh Besherdas, Gastroenterologist
❝Recommended Gastroenterologist❞
Mr Dinesh Sharma, Endocrine Surgeon
❝Recommended endocrine surgeon❞
Prof. Muntzer Mughal, Consultant General and Upper GI Surgeon
❝Recommended general surgeon❞
